Regional Account Manager-Neurology (Upper Mid West based Candidates)
Axsome Therapeutics IncSalary not specified
- Full Time
- Junior (1 to 2 years)
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, HealthcareIndustries
Requirements
Candidates are required to possess a Bachelor's degree and a minimum of 5 years of experience in biotech or pharmaceutical sales, with preference given to experience in cardiology, rare diseases, or specialty products. Experience with sole territory ownership is highly desirable, and prior specialty product launch experience is preferred.
Responsibilities
As a Cardiovascular Account Specialist, you will be responsible for introducing Cytokinetics in your territory, launching its first commercial product for Hypertrophic Cardiomyopathy (HCM), and driving sales results by developing territory-specific account plans, coordinating with internal stakeholders, and establishing relationships with strategic IDNs, hospitals, cardiology clinics, and specialty pharmacies. You will also serve as a subject matter expert, delivering clinically relevant information to healthcare professionals, communicating approved resources, and focusing on creating demand for the product launch.
Skills
Biotech sales
Pharmaceutical sales
Cardiology
Rare disease
Specialty product launch
Account planning
Stakeholder engagement
Clinical knowledge
Demand generation
Territory management
Cytokinetics
Develops drugs for muscle function disorders
About Cytokinetics
Cytokinetics focuses on developing medicines that improve muscle function for patients with cardiovascular and neuromuscular diseases. Their products are small molecule drugs designed to either enhance or inhibit muscle function, tailored to specific therapeutic needs. The company has a pipeline of drugs, including omecamtiv mecarbil and reldesemtiv, which are in various stages of clinical trials. Unlike many competitors, Cytokinetics emphasizes rigorous scientific research and has conducted over 50 clinical trials to ensure the effectiveness of its treatments. The goal is to bring new therapies to market that address the unmet needs of patients suffering from conditions like heart failure, ALS, and HCM.
Key Metrics
South San Francisco, CaliforniaHeadquarters
1998Year Founded
$58.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees